Loading...
XLONAGR
Market cap1.55bUSD
Dec 24, Last price  
37.98GBP
1D
1.50%
1Q
-9.18%
Jan 2017
-33.09%
IPO
-27.49%
Name

Assura PLC

Chart & Performance

D1W1MN
XLON:AGR chart
P/E
P/S
782.37
EPS
Div Yield, %
0.07%
Shrs. gr., 5y
4.43%
Rev. gr., 5y
9.03%
Revenues
158m
+3.82%
3,758,2247,016,00016,123,000047,571,00055,761,00062,119,00034,100,00037,100,00039,900,00051,100,00061,000,00071,100,00086,100,000102,400,000111,500,000121,000,000137,300,000152,000,000157,800,000
Net income
-29m
L-75.84%
2,231,000-12,499,00018,900,0000-108,763,000-8,682,00015,072,000-60,700,00014,100,00035,000,00037,200,00027,900,00095,300,00071,800,00084,000,00078,900,000108,300,000155,900,000-119,200,000-28,800,000
CFO
102m
+8.82%
2,190,000760,000149,0005,295,000-11,746,0002,859,00013,400,00012,900,0007,900,00016,900,00022,900,00039,000,00049,900,00072,900,00066,300,00077,400,00094,600,00094,100,000102,400,000
Dividend
Sep 05, 20240.84 GBP/sh
Earnings
May 19, 2025

Profile

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 30 September 2020, Assura's property portfolio was valued at £2,259 million.
IPO date
Jan 28, 2015
Employees
86
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
157,800
3.82%
152,000
10.71%
137,300
13.47%
Cost of revenue
28,500
26,600
23,000
Unusual Expense (Income)
NOPBT
129,300
125,400
114,300
NOPBT Margin
81.94%
82.50%
83.25%
Operating Taxes
100
700
(100)
Tax Rate
0.08%
0.56%
NOPAT
129,200
124,700
114,400
Net income
(28,800)
-75.84%
(119,200)
-176.46%
155,900
43.95%
Dividends
(85,500)
(88,900)
(75,400)
Dividend yield
Proceeds from repurchase of equity
(293,800)
BB yield
Debt
Debt current
300
400
100
Long-term debt
1,258,400
1,252,200
1,249,800
Deferred revenue
4,200
35,700
36,100
Other long-term liabilities
46,800
44,900
Net debt
1,205,800
1,116,300
1,002,600
Cash flow
Cash from operating activities
102,400
94,100
94,600
CAPEX
(2,800)
(15,200)
(3,500)
Cash from investing activities
(97,700)
(130,400)
(293,900)
Cash from financing activities
(87,300)
(89,200)
396,200
FCF
60,600
128,600
121,500
Balance
Cash
33,200
118,000
243,500
Long term investments
19,700
18,300
3,800
Excess cash
45,010
128,700
240,435
Stockholders' equity
309,400
894,600
1,102,300
Invested Capital
2,685,090
2,794,800
2,884,065
ROIC
4.72%
4.39%
4.24%
ROCE
4.74%
4.41%
3.76%
EV
Common stock shares outstanding
2,970,682
2,958,385
2,781,957
Price
Market cap
EV
EBITDA
129,600
125,600
114,500
EV/EBITDA
Interest
27,100
31,200
30,000
Interest/NOPBT
20.96%
24.88%
26.25%